These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23062983)

  • 1. Pancreas transplant as treatment to arrest renal function decline in patients with type 1 diabetes and proteinuria.
    Cantarovich D; Perrone V
    Semin Nephrol; 2012 Sep; 32(5):432-6. PubMed ID: 23062983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney function before pancreas transplant alone predicts subsequent risk of end-stage renal disease.
    Kim SJ; Smail N; Paraskevas S; Schiff J; Cantarovich M
    Transplantation; 2014 Mar; 97(6):675-80. PubMed ID: 24637866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can improved glycemic control slow renal function decline at all stages of diabetic nephropathy?
    Goel G; Perkins BA
    Semin Nephrol; 2012 Sep; 32(5):423-31. PubMed ID: 23062982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades.
    Cao C; Hellermann JP; Weber M; Ambühl PM
    Nephrol Dial Transplant; 2006 Mar; 21(3):770-5. PubMed ID: 16401627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal protection in diabetes: role of glycemic control.
    Fioretto P; Bruseghin M; Berto I; Gallina P; Manzato E; Mussap M
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S86-9. PubMed ID: 16565255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan in diabetic nephropathy.
    Perico N; Ruggenenti P; Remuzzi G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between glucose control and the development of diabetic nephropathy in type I diabetes.
    Molitch ME
    Semin Nephrol; 1997 Mar; 17(2):101-13. PubMed ID: 9148376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes.
    Bilous RW; Mauer SM; Sutherland DE; Najarian JS; Goetz FC; Steffes MW
    N Engl J Med; 1989 Jul; 321(2):80-5. PubMed ID: 2659996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function in recipients of pancreas transplant alone.
    Smail N; Paraskevas S; Tan X; Metrakos P; Cantarovich M
    Curr Opin Organ Transplant; 2012 Feb; 17(1):73-9. PubMed ID: 22186098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uremia (end-stage renal disease): how cost-effective are preventive strategies?
    Glassock RJ
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S131-4. PubMed ID: 20797562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of progression of macrovascular diseases after kidney or pancreas and kidney transplantation in diabetic patients with end-stage renal disease.
    Biesenbach G; Margreiter R; Königsrainer A; Bösmüller C; Janko O; Brücke P; Gross C; Zazgornik J
    Diabetologia; 2000 Feb; 43(2):231-4. PubMed ID: 10753046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetes and chronic kidney disease: lessons from renal epidemiology].
    Villar E; Zaoui P
    Nephrol Ther; 2010 Dec; 6(7):585-90. PubMed ID: 21075694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
    Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
    Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreas transplantation for the prevention of diabetic nephropathy.
    Stegall MD; Larson TS; Kudva YC; Grande JP; Nyberg SL; Prieto M; Velosa JA; Rizza RA
    Mayo Clin Proc; 2000 Jan; 75(1):49-56. PubMed ID: 10630757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic nephropathy.
    Ritz E
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney and kidney-pancreas transplantation in diabetic recipients.
    Pirson Y; Vandeleene B; Squifflet JP
    Diabetes Metab; 2000 Jul; 26 Suppl 4():86-9. PubMed ID: 10922978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.